1. null
   Selma D’Silva et al, 2019 CrossRef
2. Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells.
   Mattias Carlsten et al, 2019, Front Immunol CrossRef
3. Unraveling the Role of Innate Lymphoid Cells in AcuteMyeloid Leukemia
   Matthew R. Lordo et al, 2021, Cancers CrossRef
4. Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia
   Vlad Andrei Cianga et al, 2021, Front. Immunol. CrossRef
5. Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
   Natasha Mupeta Kaweme et al, 2021, Front. Immunol. CrossRef
6. Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia
   Georgios Petros Barakos et al, 2022, Diseases CrossRef
7. Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response
   Vlad Andrei Cianga et al, 2023, Front. Med. CrossRef